| USD millions | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 12.1 | 13.3 | 12.9 | 12.4 | 12.9 | 13.6 | +4.8% | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 12.1 | 13.3 | 12.9 | 12.4 | 12.9 | 13.6 | +4.8% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 1.6 | 1.7 | 1.6 | 1.6 | 1.5 | 1.3 | −7.6% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | +30.1% | |
| Operating expenses | 19.3 | 17.7 | 0.5 | 8.8 | 38.5 | 1.9 | −95.2% | |
| Operating income | 10.5 | 11.6 | 11.3 | 10.8 | 11.5 | 12.2 | +6.3% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 1.6 | 1.9 | 0.9 | 0.5 | 1.6 | 3.0 | +85.3% | |
| Other income / expense | (19.2) | 17.5 | 0.2 | (7.7) | (38.7) | 0.2 | +100.5% | |
| Pre-tax income | (8.7) | 29.1 | 11.5 | 3.1 | (27.2) | 12.4 | +145.6% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | −100.0% | |
| Net income | (8.7) | 29.1 | 11.5 | 3.1 | (27.3) | 12.4 | +145.5% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.73) | 2.45 | 0.97 | 0.26 | (2.30) | 1.05 | +145.7% | |
| EPS, diluted (per share) | (0.73) | 2.45 | 0.97 | 0.26 | (2.30) | 1.05 | +145.7% | |
| EBITDA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | — | |
| Depreciation & amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | — | |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | +0.0 pts | |
| Operating margin | 86.8% | 87.4% | 87.7% | 86.9% | 88.7% | 90.0% | +1.3 pts | |
| Net margin | −71.4% | 218.9% | 89.2% | 24.7% | −210.7% | 91.5% | +302.3 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
